557. Deputy John Lahart asked the Minister for Health his views on the forecasted levels of biosimilar and generic medicines substitution in 2024 and expected budget savings from same; whether funding for new medicines in 2024 will be entirely dependent on savings made in other parts of the overall medicines budget in 2024, given no additional funding for next year; whether he expects delays in access to new therapies as a result; how many industry submissions were made in the July horizon scan for Budget 2024 consideration; and if he will make a statement on the matter. [50995/23]

Summary

557. Deputy John Lahart asked the Minister for Health his views on the forecasted levels of biosimilar and generic medicines substitution in 2024 and expected budget savings from same; whether funding for new medicines in 2024 will be entirely dependent on savings made in other parts of the overall medicines budget in 2024, given no additional funding for next year; whether he expects delays in access to new therapies as a result; how many industry submissions were made in the July horizon scan for Budget 2024 consideration; and if he will make a statement on the matter. [50995/23]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 21 November 2023

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.